Literature DB >> 17278060

Human T lymphotropic virus type 1 (HTLV-1) proviral load in asymptomatic carriers, HTLV-1-associated myelopathy/tropical spastic paraparesis, and other neurological abnormalities associated with HTLV-1 infection.

Marcus Tulius T Silva1, Ramza Cabral Harab, Ana Cláudia Leite, Doris Schor, Abelardo Araújo, Maria José Andrada-Serpa.   

Abstract

Recent reports have demonstrated that human T lymphotropic virus type 1 (HTLV-1) is associated with other neurological abnormalities in addition to HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). It has been well established that high HTLV-1 proviral loads are associated with the development of HAM/TSP. We now demonstrate, for the first time, to our knowledge, that HTLV-1 proviral loads in patients with other neurological abnormalities are also significantly higher than in asymptomatic HTLV-1 carriers.

Entities:  

Mesh:

Year:  2007        PMID: 17278060     DOI: 10.1086/510679

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  20 in total

1.  Immunological and viral features in patients with overactive bladder associated with human T-cell lymphotropic virus type 1 infection.

Authors:  Silvane Braga Santos; Paulo Oliveira; Tania Luna; Anselmo Souza; Márcia Nascimento; Isadora Siqueira; Davi Tanajura; André Luiz Muniz; Marshall J Glesby; Edgar M Carvalho
Journal:  J Med Virol       Date:  2012-11       Impact factor: 2.327

2.  Human T-lymphotropic virus type 2 subtype b in a patient with chronic neurological disorder.

Authors:  Carolina Rosadas; Ana C P Vicente; Louise Zanella; Mauro J Cabral-Castro; José M Peralta; Marzia Puccioni-Sohler
Journal:  J Neurovirol       Date:  2014-09-03       Impact factor: 2.643

3.  Clinical manifestations in individuals with recent diagnosis of HTLV type I infection.

Authors:  Shelene K W Poetker; Aurelia F Porto; Silvana P Giozza; Andre L Muniz; Marina F Caskey; Edgar M Carvalho; Marshall J Glesby
Journal:  J Clin Virol       Date:  2011-03-08       Impact factor: 3.168

4.  Neurological symptoms and signs in HTLV-1 patients with overactive bladder syndrome.

Authors:  Davi Tanajura Costa; André Luiz Muniz Alves dos Santos; Néviton Matos de Castro; Isadora Cristina de Siqueira; Edgar Marcelino de Carvalho Filho; Marshall Jay Glesby
Journal:  Arq Neuropsiquiatr       Date:  2012-04       Impact factor: 1.420

5.  Utility of HTLV proviral load quantification in diagnosis of HTLV-1-associated myelopathy requires international standardization.

Authors:  Maria Fernanda Rios Grassi; Viviana Nilla Olavarria; Ramon de Almeida Kruschewsky; Yoshihisa Yamano; Steven Jacobson; Graham P Taylor; Fabiola Martin; Bernardo Galvão-Castro
Journal:  J Clin Virol       Date:  2013-09-13       Impact factor: 3.168

6.  Increasing utilization of human T-cell lymphotropic virus (+) donors in liver transplantation: is it safe?

Authors:  Michael R Marvin; Guy N Brock; Kwadwo Kwarteng; Ravi Nagubandi; Kadiyala V Ravindra; Mary Eng; Joseph F Buell
Journal:  Transplantation       Date:  2009-04-27       Impact factor: 4.939

7.  Neurologic abnormalities in HTLV-I- and HTLV-II-infected individuals without overt myelopathy.

Authors:  H H Biswas; J W Engstrom; Z Kaidarova; G Garratty; J W Gibble; B H Newman; J W Smith; A Ziman; J L Fridey; R A Sacher; E L Murphy
Journal:  Neurology       Date:  2009-09-08       Impact factor: 9.910

8.  HTLV-1 proviral load in cerebrospinal fluid may not be a good marker to differentiate asymptomatic carriers with high proviral load in blood from HAM/TSP patients.

Authors:  Marina Lobato Martins; Anna Bárbara de Freitas Carneiro-Proietti; Rodrigo Nicolato; Débora Marques de Miranda; Luiz Cláudio Ferreira Romanelli
Journal:  J Neurovirol       Date:  2018-03-27       Impact factor: 2.643

9.  Adult T-cell leukemia/lymphoma: a case report of primary cutaneous tumoral type.

Authors:  Julia Ocampo Lyra-da-Silva; Yung Bruno de Mello Gonzaga; Otávio de Melo Espíndola; Maria José de Andrada-Serpa; Cassio Dib; Thiago Jeunon
Journal:  Dermatol Pract Concept       Date:  2012-04-30

10.  Human T-lymphotropic virus 1 neurologic disease.

Authors:  Abelardo Araújo; Marco Antonio Lima; Marcus Tulius T Silva
Journal:  Curr Treat Options Neurol       Date:  2008-05       Impact factor: 3.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.